Details for New Drug Application (NDA): 020749
✉ Email this page to a colleague
The generic ingredient in LAMISIL is terbinafine. There are twenty-seven drug master file entries for this compound. Additional details are available on the terbinafine profile page.
Summary for 020749
Tradename: | LAMISIL |
Applicant: | Karo Hlthcare |
Ingredient: | terbinafine hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | 1% | ||||
Approval Date: | Oct 17, 1997 | TE: | RLD: | No |
Expired US Patents for NDA 020749
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Karo Hlthcare | LAMISIL | terbinafine hydrochloride | SOLUTION;TOPICAL | 020749-001 | Oct 17, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Karo Hlthcare | LAMISIL | terbinafine hydrochloride | SOLUTION;TOPICAL | 020749-001 | Oct 17, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription